EP0876145A4 - Taxane composition and method - Google Patents

Taxane composition and method

Info

Publication number: EP0876145A4
Authority: EP; European Patent Office
Prior art keywords: taxane composition; taxane; composition
Prior art date: 1995-12-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

EP96943805A

Other languages

German (de)

French (fr)

Other versions

EP0876145A1 (en

Inventor

Bijan Almassian

William Choy

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Genelabs Technologies Inc

Original Assignee

Genelabs Technologies Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-21

Filing date

1996-12-19

Publication date

1999-04-21

1996-12-19 Application filed by Genelabs Technologies Inc filed Critical Genelabs Technologies Inc

1998-11-11 Publication of EP0876145A1 publication Critical patent/EP0876145A1/en

1999-04-21 Publication of EP0876145A4 publication Critical patent/EP0876145A4/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Dispersion Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Epoxy Compounds (AREA)
Medicinal Preparation (AREA)

EP96943805A 1995-12-21 1996-12-19 Taxane composition and method Ceased EP0876145A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US57620495A	1995-12-21	1995-12-21
US576204		1995-12-21
PCT/US1996/020187 WO1997023208A1 (en)	1995-12-21	1996-12-19	Taxane composition and method

Publications (2)

Publication Number	Publication Date
EP0876145A1 EP0876145A1 (en)	1998-11-11
EP0876145A4 true EP0876145A4 (en)	1999-04-21

Family

ID=24303400

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP96943805A Ceased EP0876145A4 (en)	1995-12-21	1996-12-19	Taxane composition and method

Country Status (6)

Country	Link
EP (1)	EP0876145A4 (en)
KR (1)	KR970032859A (en)
CN (1)	CN1209059A (en)
AU (1)	AU724842B2 (en)
CA (1)	CA2240595A1 (en)
WO (1)	WO1997023208A1 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6964946B1 (en) *	1995-10-26	2005-11-15	Baker Norton Pharmaceuticals, Inc.	Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
US5922754A (en) *	1998-10-02	1999-07-13	Abbott Laboratories	Pharmaceutical compositions containing paclitaxel
EP1479382A1 (en) *	1999-06-18	2004-11-24	IVAX Research, Inc.	Oral pharmaceutical compositions containing taxanes and methods for treatment employing the same
US6919370B2 (en) *	2000-11-28	2005-07-19	Transform Pharmaceuticals, Inc.	Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
JP2008543789A (en) *	2005-06-17	2008-12-04	ホスピラオーストラリアピーティーワイエルティーディー	Docetaxel liquid pharmaceutical formulation
GB0517092D0 (en) *	2005-08-19	2005-09-28	Novartis Ag	New compositions containing taxane derivatives
BRPI0600194A (en) *	2006-01-30	2007-10-23	Quiral Quimica Do Brasil S A	docetaxel-containing pharmaceutical compositions and a degradation inhibitor and process for obtaining same
CN101023940A (en) *	2006-02-20	2007-08-29	郝守祝	Medicine composition of Taxane compounds, preparing method and use
CN100595270C (en) *	2006-04-12	2010-03-24	中国科学院大连化学物理研究所	Microorganism capable of hydrolyzing glycosyl to hydroxyl and application thereof
RU2398578C2 (en) *	2006-05-03	2010-09-10	И.К.А., А.С.	Pharmaceutical composition containing taxan derivative and used for preparation of infusion solution, method for preparation and application
WO2007134354A1 (en) *	2006-05-23	2007-11-29	Ebewe Pharma Ges.M.B.H. Nfg. Kg	Pharmaceutical formulation
EP1946747A1 (en) *	2007-01-17	2008-07-23	Sandoz AG	Pharmaceutical composition of improved stability containing taxane derivatives
CZ200756A3 (en) *	2007-01-23	2008-07-30	Heaton, A. S.	Taxane-containing two-component pharmaceutical composition
CN101396354B (en) *	2007-09-30	2010-12-01	江苏恒瑞医药股份有限公司	Stable taxabe compound liquid combination and preparation method and use thereof
EP2077132A1 (en)	2008-01-02	2009-07-08	Boehringer Ingelheim Pharma GmbH & Co. KG	Dispensing device, storage device and method for dispensing a formulation
KR101053780B1 (en) *	2008-02-29	2011-08-02	동아제약주식회사	Single liquid stable pharmaceutical composition containing docetaxel
ES2344674B1 (en)	2008-08-07	2011-06-29	Gp Pharm, S.A.	INJECTABLE PHARMACEUTICAL COMPOSITION OF TAXANOS.
WO2010112358A2 (en)	2009-03-31	2010-10-07	Boehringer Ingelheim International Gmbh	Method for coating a surface of a component
EP2432531B1 (en)	2009-05-18	2019-03-06	Boehringer Ingelheim International GmbH	Adapter, inhalation device and nebulizer
JP5715640B2 (en)	2009-11-25	2015-05-13	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Nebulizer
EP2504051B1 (en)	2009-11-25	2019-09-04	Boehringer Ingelheim International GmbH	Nebulizer
US10016568B2 (en)	2009-11-25	2018-07-10	Boehringer Ingelheim International Gmbh	Nebulizer
EP2585151B1 (en)	2010-06-24	2018-04-04	Boehringer Ingelheim International GmbH	Nebulizer
WO2012130757A1 (en)	2011-04-01	2012-10-04	Boehringer Ingelheim International Gmbh	Medical device comprising a container
US9827384B2 (en)	2011-05-23	2017-11-28	Boehringer Ingelheim International Gmbh	Nebulizer
WO2013141346A1 (en) *	2012-03-22	2013-09-26	塩水港精糖株式会社	Method for producing liposome encapsulating paclitaxel monoglycoside and/or docetaxel monoglycoside
WO2013152894A1 (en)	2012-04-13	2013-10-17	Boehringer Ingelheim International Gmbh	Atomiser with coding means
JO3685B1 (en) *	2012-10-01	2020-08-27	Teikoku Pharma Usa Inc	Non-aqueous taxane nanodispersion formulations and methods of using the same
PL2835146T3 (en)	2013-08-09	2021-04-06	Boehringer Ingelheim International Gmbh	Nebulizer
EP3030298B1 (en)	2013-08-09	2017-10-11	Boehringer Ingelheim International GmbH	Nebulizer
AU2015257878B2 (en)	2014-05-07	2019-08-08	Boehringer Ingelheim International Gmbh	Container, nebulizer and use
JP6559157B2 (en)	2014-05-07	2019-08-14	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Nebulizer
WO2015169428A2 (en)	2014-05-07	2015-11-12	Boehringer Ingelheim International Gmbh	Nebulizer
TWI715636B (en) *	2015-09-30	2021-01-11	香港商慧源香港創新有限公司	Oral taxane compositions and methods
CN110382524B (en)	2017-01-16	2024-02-06	南沙生物科技(香港)公司	Systems and methods for producing recombinant IL-11 in yeast

Citations (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0253738A1 (en) *	1986-07-17	1988-01-20	Rhone-Poulenc Sante	Taxol derivatives, their preparation and pharmaceutical compositions containing them
EP0522936A1 (en) *	1991-07-08	1993-01-13	Aventis Pharma S.A.	Taxane derivatives containing compositions
WO1994012198A1 (en) *	1992-11-27	1994-06-09	F.H. Faulding & Co. Limited	Injectable taxol composition
WO1994012171A1 (en) *	1992-12-02	1994-06-09	Rhone-Poulenc Rorer S.A.	Injectable taxane derivative based compositions
WO1994012030A1 (en) *	1992-11-27	1994-06-09	Napro Biotherapeutics, Inc.	Injectable composition
EP0645145A2 (en) *	1993-09-29	1995-03-29	Bristol-Myers Squibb Company	Stabilized pharmaceutical composition and stabilizing solvent
WO1996029070A1 (en) *	1995-03-17	1996-09-26	The Board Of Regents, The University Of Texas System	Extended stability formulations for paclitaxel

1996
- 1996-12-19 AU AU12949/97A patent/AU724842B2/en not_active Withdrawn - After Issue
- 1996-12-19 CA CA002240595A patent/CA2240595A1/en not_active Abandoned
- 1996-12-19 WO PCT/US1996/020187 patent/WO1997023208A1/en not_active Application Discontinuation
- 1996-12-19 CN CN96199939A patent/CN1209059A/en active Pending
- 1996-12-19 EP EP96943805A patent/EP0876145A4/en not_active Ceased
- 1996-12-20 KR KR1019960069000A patent/KR970032859A/en not_active Application Discontinuation

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0253738A1 (en) *	1986-07-17	1988-01-20	Rhone-Poulenc Sante	Taxol derivatives, their preparation and pharmaceutical compositions containing them
EP0522936A1 (en) *	1991-07-08	1993-01-13	Aventis Pharma S.A.	Taxane derivatives containing compositions
EP0522937A1 (en) *	1991-07-08	1993-01-13	Aventis Pharma S.A.	Taxane derivatives containing compositions
WO1994012198A1 (en) *	1992-11-27	1994-06-09	F.H. Faulding & Co. Limited	Injectable taxol composition
WO1994012030A1 (en) *	1992-11-27	1994-06-09	Napro Biotherapeutics, Inc.	Injectable composition
WO1994012171A1 (en) *	1992-12-02	1994-06-09	Rhone-Poulenc Rorer S.A.	Injectable taxane derivative based compositions
EP0645145A2 (en) *	1993-09-29	1995-03-29	Bristol-Myers Squibb Company	Stabilized pharmaceutical composition and stabilizing solvent
WO1996029070A1 (en) *	1995-03-17	1996-09-26	The Board Of Regents, The University Of Texas System	Extended stability formulations for paclitaxel

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
B.D.TARR ET AL.: "A NEW PARENTERAL VEHICLE FOR THE ADMINISTRATION OF SOME POORLY SOLUBLE ANTI-CANCER DRUGS", J. PARENTER. SCI. TECHNOL., vol. 41, no. 1, 1987, pages 31 - 33 *
CHEMICAL ABSTRACTS, vol. 106, no. 22, 1 June 1987, Columbus, Ohio, US; abstract no. 182581c, XP002054344 *
See also references of WO9723208A1 *

Also Published As

Publication number	Publication date
WO1997023208A1 (en)	1997-07-03
AU1294997A (en)	1997-07-17
AU724842B2 (en)	2000-09-28
CN1209059A (en)	1999-02-24
EP0876145A1 (en)	1998-11-11
KR970032859A (en)	1997-07-22
CA2240595A1 (en)	1997-07-03

Publication	Publication Date	Title
EP0876145A4 (en)	1999-04-21	Taxane composition and method
ZA963844B (en)	1996-11-21	Seed treatment composition and method
ZA967841B (en)	1998-03-17	Antiplaque oral composition and method.
GB2298713B (en)	1999-12-15	Method and composition
EP0851759A4 (en)	2000-12-06	Compounds and methods
ZA989400B (en)	1999-04-15	Method and composition
GB9500856D0 (en)	1995-03-08	Composition and use
ZA989398B (en)	1999-04-15	Method and composition (l)
GB9624501D0 (en)	1997-01-15	Insecticial compositions and method
AUPN137895A0 (en)	1995-03-16	Composition and method
GB2329584B (en)	1999-08-04	Cosmetic composition and its producing method
GB2318356B (en)	1999-03-10	Composition and method
PL322591A1 (en)	1998-02-02	Soaking composition
GB9224295D0 (en)	1993-01-06	Method and composition
GB9408342D0 (en)	1994-06-15	Method and composition
GB2300639B (en)	1999-04-14	Polyurethane compositions and method
GB9523843D0 (en)	1996-01-24	Cosmetic composition and method
GB9414888D0 (en)	1994-09-14	Method and composition
GB9419087D0 (en)	1994-11-09	Method and composition
GB9503315D0 (en)	1995-04-12	Composition and method
GB9503772D0 (en)	1995-04-12	Method and composition
GB9308051D0 (en)	1993-06-02	Method and composition
GB9512703D0 (en)	1995-08-23	Composition and use
GB9422616D0 (en)	1995-01-04	Method and composition
GB9601656D0 (en)	1996-03-27	Novel composition and method

Legal Events

Date	Code	Title	Description
1998-09-25	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1998-11-11	17P	Request for examination filed	Effective date: 19980720
1998-11-11	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
1999-04-21	A4	Supplementary search report drawn up and despatched	Effective date: 19990310
1999-04-21	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
1999-04-28	RTI1	Title (correction)
2000-11-20	GRAG	Despatch of communication of intention to grant	Free format text: ORIGINAL CODE: EPIDOS AGRA
2001-01-10	17Q	First examination report despatched	Effective date: 20001123
2001-10-19	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED
2001-12-05	18R	Application refused	Effective date: 20010525